Inicio › Cáncer de vías biliares › California

Ensayos clínicos de Cáncer de vías biliares en California

20 estudios sobre Cáncer de vías biliares buscan participantes en California.

Ciudades en California

Texto oficial del estudio (inglés)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06760819

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site, Orange
Research Site, Palo Alto
Research Site, Santa Rosa

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06219941

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

City of Hope (Site 107), Duarte
University of California at Irvine (Site 101), Orange
UCLA Medical Center (Site 117), Santa Monica

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07265674

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
USC Norris Comprehensive Cancer Center, Los Angeles

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05482893

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Research Site, Duarte
Research Site, Los Angeles
Research Site, Orange
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07221253

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

UCLA ( Site 0317), Los Angeles

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06428409

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Los Angeles
Research Site, Santa Rosa

ReclutandoFase 2

Edades de 18 a 130 · Todos los sexos · Actualizado el 23 sept 2026 · NCT05489211

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06293898

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Los Angeles
Avenzo Therapeutics Recruiting Site, Los Angeles

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07038343

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Hoag Family Cancer Institute, Newport Beach

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06774963

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Research Site, Fullerton
Research Site, La Jolla
Research Site, Los Angeles
y 3 más

ReclutandoFase 3

Edades de 18 a 99 · Todos los sexos · Actualizado el 19 ago 2026 · NCT06467357

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Los Angeles Cancer Network, Los Angeles
Pih Health Hematology Medical Oncology, Whittier

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06330064

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Precision NextGen Oncology & Research Center, Beverly Hills
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
University of California Los Angeles Rheumatology, Westwood, Los Angeles

ReclutandoFase 2

Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

University of California, Davis Comprehensive Cancer Center, Sacramento

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jul 2026 · NCT06101277

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Cedars-Sinai Medical Center, Los Angeles

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT07458347

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

The City of Hope National Medical Center, Duarte
Hoag Memorial Hospital, Newport Beach

ReclutandoFase 1

Edades de 16 en adelante · Todos los sexos · Actualizado el 2 jun 2026 · NCT07197554

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Beverly Hills Cancer Center, Beverly Hills
UC San Diego Moores Cancer Center, La Jolla

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 abr 2026 · NCT05733598

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Stern Center for Cancer Clinical Trials and Research, Orange

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT04900818

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Cedars-Sinai Medical Center, Los Angeles

Reclutando

Edades de 18 a 99 · Todos los sexos · Actualizado el 20 feb 2026 · NCT04907643

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

University of Southern California, Los Angeles

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 dic 2025 · NCT06943521

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.